Aktuellt
Vironova to co-develop unique virus and nanoparticle analysis equipment in a €1,72 million EU granted project
Pressmeddelande 2011-04-14 09:37Vironova today announces grant funding from the EU for a €1,72 million EurostarsTM project - “MiniTEM” - aiming at developing the world’s first portable transmission electron microscope for identification of viruses and characterization of biological nanoparticles. The project was ranked nr 2 out of 110 qualified applications from companies and Universities around Europe within diverse industries.
Vironova leads a new Influenza drug development program with EU funding of 6M Euros
Pressmeddelande 2011-02-22 07:59
STOCKHOLM – 22 february, 2011 – Vironova today announces Grant funding of 6MEuros to support influenza drug development.
Vironova öppnar unikt viruslaboratorium för nordiska bioteknikföretag
Pressmeddelande 2011-02-01 08:00 Bioteknikföretaget Vironova AB (publ) – meddelar att man torsdagen den 10 februari inviger sitt nya laboratorium för virusvalideringsstudier. I den nybyggda faciliteten i centrala Stockholm nära Karolinska Institutet kommer Vironova att kunna erbjuda den växande nordiska bioteknikindustrin de virussäkerhetsstudier som krävs under utvecklingen av nya biologiska läkemedel och vacciner.
Bilder
Videor
-
Vironova - virus diagnostics and antiviral drug development
Get an impression of Vironova's ground breaking virus detection and analysis software. It provides tools for rapid and objective virus diagnostics and fast screenng of potential antiviral substances. It's a technology which can eliminate the viral threat - where ever its origin may be.
-
Size of an Adenovirus by Gustaf Kylberg
How small is small?? Have a look at this video to get an idea....
